In a retrospective study, researchers investigated the autoantibody profile and clinical characteristics of patients with refractory myasthenia gravis, compared to patients nonrefractory status, based on predefined criteria.
Researchers sought to identify biomarkers across different types of Charcot-Marie-Tooth disease by analyzing blood samples from both mouse models and patients.
In a retrospective, observational study, researchers determined the impact of COVID-19 infection in patients with myasthenia gravis.
Researchers sought to determine the clinical, immunologic, and therapeutic characteristics in patients with drug-refractory myasthenia gravis and to determine the effectiveness and side effects of drugs used for treatment.
Researchers sought to explore the genetic landscape of cerebral palsy using whole exome sequencing in a cohort of patients with cerebral palsy.
Researchers sought to assess the outcomes of invasive ventilation, mortality, and hospital length of stay among patients presenting with myasthenia gravis and COVID-19.
In a retrospective study, researchers analyzed the potential association between anti-acetylcholine receptor antibody serum levels and the clinical improvement of myasthenia gravis.
Researchers sought to validate the modified Erasmus GBS Outcome Score, a clinical model that predicts the inability to walk in patients with GBS, in the International GBS Outcome Study cohort, observe any regional variations in performance, and improve predictions by adjusting accordingly.
Researchers sought to assess the loss of insight related to behavioral changes across cognitive profiles in amyotrophic lateral sclerosis subgroups.
In a prospective natural history study, researchers tested the association between body mass index and height and clinical characteristics in Friedreich ataxia.
